-
Validation of a real- time monitoring system to detect motor symptoms in patients with Parkinson´s disease treated with Levodopa Carbidopa Intestinal Gel
-
Validation of biomarkers in Huntington’s disease to support the development of disease-modifying therapies: a systematic review and critical appraisal scheme
-
Validation of postural tremor model using regression and optimization
-
Validation of smartphone-based active tests with structural neuroimaging in Huntington’s disease
-
Validation of the Neuroprotective Potential of SLP-2 against alpha-synuclein neuropathology in a Mouse Model of Parkinson’s Disease
-
Validation of the Thai version of the MDS-UPDRS
-
Validation of the UCLA Loneliness Scale in Parkinson’s Disease During a Period of Social Distancing
-
Validity and Reliability of Timed Get-Up and Go Test and Unified Parkinson’s disease Rating Scales on Parkinson ’s disease
-
Validity of quantitative parameters for analyzing gait motion in PD patients after STN-DBS
-
Variability of tremor is not always functional: A feasibility study on the aetiological differentiation of tremor
-
Ventilatory function and respiratory muscle strength in Parkinson’s disease at the early stage: observational study.
-
Virtual reality for balance and mobility in Parkinson’s disease: systematic review and meta-analysis
-
Virtual Rehabilitation for Functional Movement Disorder
-
Visual cognition differences between asymptomatic and symptomatic carriers of Huntington’s disease (HD)
-
Visual Impairment along Parkinsonism Development and the Association to Non-vision dependent Cognitive Decline: A Prospective Nation-wide CLSA study
-
Visualising tau in patients with progressive supranuclear palsy using PI2620-PET
-
Visualization Tool for DBS Programming with a Multiple Source, Constant Current System Reduces Initial Programming Time
-
Visuo-cognitive training in Parkinson’s disease: Protocol for a randomised cross-over trial.
-
Vitamin D and Parkinson’s disease
-
VMAT2 availability in Parkinson’s Disease with Rapid Eye Movement Sleep Behaviour Disorder
-
VMAT2 OVEREXPRESSION REDUCES INTRACELLULAR NEUROMELANIN LEVELS AND ATTENUATES PARKINSON-LIKE PATHOLOGY IN NEUROMELANIN-PRODUCING PARKINSONIAN RATS
-
VPS35 D620N knockin mice recapitulate cardinal features of Parkinson’s disease
MDS Virtual Congress 2021
September 17-22, 2021. Virtual Congress. www.mdscongress.org